FDA Under Scrutiny: Congress Presses Agency On Antidepressants, Plan B
Executive Summary
Congress is asking FDA to document its actions in two high-profile agency decisions
You may also be interested in...
FDA Drug Safety Office Is “Separate, But Unequal,” Senate Committee Says
A Senate committee investigation into FDA's handling of pediatric suicidality concerns with antidepressant drugs is focusing on the "unequal" status of the Office of Drug Safety and the Office of New Drugs
FDA Drug Safety Office Is “Separate, But Unequal,” Senate Committee Says
A Senate committee investigation into FDA's handling of pediatric suicidality concerns with antidepressant drugs is focusing on the "unequal" status of the Office of Drug Safety and the Office of New Drugs
FDA Handling Of Antidepressant Inquiry “Troubles” Senate Investigators
The Senate Finance Committee is asking for contact information for former employees of FDA's Office of Drug Safety in its continuing investigation into the agency's handling of information on a possible link between antidepressants and suicide